首页> 外文期刊>Phytotherapy research: PTR >Coriolus versicolor-derived protein-bound polysaccharides trigger the caspase-independent cell death pathway in amelanotic but not melanotic melanoma cells
【24h】

Coriolus versicolor-derived protein-bound polysaccharides trigger the caspase-independent cell death pathway in amelanotic but not melanotic melanoma cells

机译:Veriolus versicolor衍生的蛋白质结合多糖触发了Amelisotic但不是黑色素黑色素瘤细胞中的Caspase无关的细胞死亡途径

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have investigated the potential cell death mechanism promoted by Coriolus versicolor fungus-derived protein-bound polysaccharides (PBPs) in melanoma cells. Knowing that melanogenesis has the potential to affect the tumor behavior and melanoma therapy outcome, the cytotoxic effects of PBPs were evaluated in human SKMel-188 melanoma cell line, whose phenotype, amelanotic versus pigmented, depends on the concentration of melanin precursors in the culture medium. Our results showed that inhibitory effect of PBPs (100 and 200 mu g/ml) towards melanoma cells is inversely associated with the pigmentation level. This cytotoxicity induced in nonpigmented melanoma cells by PBPs was caspase-independent; however, it was accompanied by an increased intracellular reactive oxygen species (ROS) generation. The ROS production was controlled by c-Jun N-terminal kinase (JNK) because SP600125, a JNK inhibitor, significantly reduced ROS generation and protected cells against PBPs-induced death. We also found that PBPs-induced lactate dehydrogenase release in amelanotic melanoma cells was abolished by co-treatment with receptor-interacting serine/threonine-protein kinase 1 inhibitor, implying engagement of this kinase in PBPs-induced death pathway. The results suggest that PBPs induce an alternative programmed cell death, regulated by receptor-interacting protein-1 and ROS and that this process is modified by melanin content in melanoma cells. These findings are remarkable when considering the use of commercially available Coriolus versicolor by patients who suffer from melanoma cancer.
机译:我们研究了黑色素瘤细胞中的科罗拉斯Versicolor真菌衍生蛋白结合多糖(PBP)促进的潜在细胞死亡机制。了解素质生成具有影响肿瘤行为和黑素瘤治疗结果的潜力,在人Skmel-188黑色素瘤细胞系中评价了PBP的细胞毒性作用,其表型,氨霉素与着色,取决于培养基中黑色素前体的浓度。我们的研究结果表明,PBPS(100和200μg/ ml)对黑素瘤细胞的抑制作用与色素沉着水平相反。通过PBPS在非染色的黑色素瘤细胞中诱导的这种细胞毒性是独立于Caspase的;然而,它伴随着增加的细胞内反应性氧(ROS)产生。 ROS生产由C-6月N-末端激酶(JNK)控制,因为SP600125,JNK抑制剂,显着降低了对PBPS诱导的死亡的ROS产生和受保护的细胞。我们还发现,通过与受体相互作用的丝氨酸/苏氨酸 - 蛋白激酶1抑制剂共同处理,消除了在Amelisotic Selanoma细胞中的PBPS诱导的乳酸脱氢酶释放,暗示该激酶在PBPS诱导的死亡途径中的接合。结果表明,PBP诱导替代编程的细胞死亡,通过受体相互作用蛋白-1和RO调节,并且该方法通过黑素瘤细胞中的黑色素含量进行修饰。当考虑患有黑色素瘤癌症的患者的患者使用商业上可获得的科利洛斯葡萄球菌时,这些发现是显着的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号